Business
Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025
LOS ANGELES, March 26, 2025--Puma Biotechnology will present clinical data on its drug neratinib in a poster presentation on April 28 at the 2025 AACR Annual Meeting.
About this update from Puma Biotechnology Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2400,"height":800,"url":"https://media.zenfs.com/en/business-wire.com/0d7ddc99fe74792aed3213ac234a7ea8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/II.ooPyt.seZqtx6cIfRsg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0d7ddc99fe74792aed3213ac234a7ea8","width":960,"height":320},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/tQJgQ4XG2Q9_BED.hRuOQA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/0d7ddc99fe74792aed3213ac234a7ea8","width":1200,"height":400}},"lazy":false},{"type":"text","content":"LOS ANGELES, March 26, 2025--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that clinical data on neratinib will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025. The AACR Annual Meeting will be held at the McCormick Place in Chicago, Illinois, from April 25–30, 2025. The title of the poster that will be presented is now available on the AACR Annual Meeting website at https://www.abstractsonline.com/pp8/#!/20273/presentation/10447. The full poster will be available on the Puma website concurrent with the live presentation.","length":617,"tagName":"p"},{"type":"text","content":"Poster Session: First-in-Human Phase I Clinical Trials 1","length":56,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Abstract CT071: Title: Phase I trial of trastuzumab deruxtecan in combination with neratinib in solid tumors with HER2 alterations (NCI 10495)Authors: Andrew A. Davis, Haeseong Park, Ecaterina E. Dumbrava, Nataliya V. Uboha, Aparna Kalyan, Farshid Dayyani, Mili Arora, Miguel A. Villalona-Calero, Haider S. Mahdi, Reema A. Patel, Floor Backes, Jessica Porzel, Whitney L. Hensing, Cheryl Pickett, Cynthia X. Ma, Ron BosePresenter: Andrew Davis, MD, Washington University School of MedicineDate/Time: April 28, 2025, 2:00–5:00 p.m. CT","length":535,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":535,"olType":false},{"type":"text","content":"About Puma Biotechnology","length":24,"tagName":"p"},{"type":"text","content":"Puma Biotechnology, Inc. is a biopharmaceutical company with a ...